Schedule 13D ownership disclosure

ARS Pharmaceuticals Inc

Security class unavailable · CUSIP: 82835W108

Event date: 2023-08-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,759,678
Percent of class
7.0700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-097323
Form type
SC 13D
Filer
ARS Pharmaceuticals, Inc.
CIK
CIK 1671858
Filed
Aug 31, 2023
Reporting period
Aug 29, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub

SC 13D | SEC Filings Hub